PT Kimia Farma Tbk (IDX:KAEF)

Market Cap	2.84T
Revenue (ttm)	9.57T
Net Income (ttm)	-841.72B
Shares Out	5.57B
EPS (ttm)	-151.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	572,800
Average Volume	1,804,015
Open	510.00
Previous Close	510.00
Day's Range	505.00 - 515.00
52-Week Range	324.00 - 905.00
Beta	1.47
RSI	35.96
Earnings Date	Aug 14, 2025

About PT Kimia Farma Tbk

PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as well as trades in and distributes drugs to pharmacies, hospital pharmacy installation, medical center, and drug store. In addition, it produces quinine sa...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1817
• Employees: 5,946
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KAEF

Financial Performance

In 2024, PT Kimia Farma Tbk's revenue was 9.94 trillion, an increase of 0.68% compared to the previous year's 9.87 trillion. Losses were -842.27 billion, -57.12% less than in 2023.